TRACKING SYSTEM FOR ALTERNATIVE METHODS TOWARDS REGULATORY ACCEPTANCE
TSAR indicates the stages methods have reached in terms of acceptance as a recognised test method for use in various sectors together with a summary description. Where available, TSAR also includes relevant records and documents associated with a method linked to the different steps of the entire process: submission, validation, peer-review, recommendations and regulatory acceptance including international standards represented in the tracking system.

Results 11 - 15 of 144
Download (Excel compatible)
Thyroid method 3b: Thyroxine-binding prealbumin (TTR) binding using fluorescence displacement (T4-FITC)
TM Status: Open
Test Method Number: TM2019-09 (EU)
Short Name of TM: T4-FITC
Responsible Organisation: EURL ECVAM - European Union 
Topic(s): Endocrine disruption
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
Thyroid method 3a: Thyroxine-binding prealbumin (TTR) / thyroxine-binding globulin (TBG) binding using fluorescence displacement (ANSA)
TM Status: Open
Test Method Number: TM2019-08 (EU)
Short Name of TM: ANSA-FD
Responsible Organisation: EURL ECVAM - European Union 
Topic(s): Endocrine disruption
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
Thyroid method 2d: Activation of the sodium iodide symporter (NIS) based on Sandell-Kolthoff reaction
TM Status: Open
Test Method Number: TM2019-07 (EU)
Short Name of TM: NIS-SKR
Responsible Organisation: EURL ECVAM - European Union 
Topic(s): Endocrine disruption
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
Thyroid method 2a: Thyroperoxidase (TPO) inhibition based on oxidation of Amplex UltraRed
TM Status: Open
Test Method Number: TM2019-04 (EU)
Short Name of TM: AUR-TPO
Responsible Organisation: EURL ECVAM - European Union 
Topic(s): Endocrine disruption
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards
Thyroid method 1a: PATHHUNTER® BETA-ARRESTIN thyrotropin-releasing hormone (TRH) receptor activation (beta-galactosidase) measuring agonist and antagonist activities
TM Status: Open
Test Method Number: TM2019-02 (EU)
Short Name of TM: TRH-CHOK1
Responsible Organisation: EURL ECVAM - European Union 
Topic(s): Endocrine disruption
  •  
    Submission
  •  
    Validation
  •  
    Peer-review
  •  
    Recommendation
  •  
    Regulatory acceptance/Standards